학술논문

Neuroendocrine differentiation in head and neck squamous cell carcinoma.
Document Type
Article
Source
Journal of Laryngology & Otology. Dec2012, Vol. 126 Issue 12, p1261-1270. 10p.
Subject
*ELECTRON microscopy
*HEAD tumors
*IMMUNOHISTOCHEMISTRY
*NECK tumors
*NEUROENDOCRINE tumors
*SOMATOSTATIN
*SQUAMOUS cell carcinoma
*STATISTICAL hypothesis testing
*STATISTICS
*SURVIVAL analysis (Biometry)
*DATA analysis software
*DESCRIPTIVE statistics
*KAPLAN-Meier estimator
*DISEASE complications
Language
ISSN
0022-2151
Abstract
Objective:Tumours with neuroendocrine differentiation frequently express chromogranin A, synaptophysin and somatostatin receptors. The role of neuroendocrine differentiation in head and neck squamous cell carcinoma is not yet clear.Method:The presence of chromogranin A, synaptophysin and somatostatin receptors was studied immunohistochemically in 78 head and neck squamous cell carcinoma specimens.Results:Sparse chromogranin A expression was found in 41 per cent, associated with high chromogranin A messenger RNA expression and the presence of dense core granules. Low synaptophysin expression was found in 18 per cent. The highest staining scores were found for somatostatin receptor 5 (82 per cent), followed by somatostatin receptor 1 (69 per cent) and somatostatin receptor 2 (54 per cent), whereas somatostatin receptors 3 and 4 expression was low. Expression was not correlated with tumour stage or survival.Conclusion:Cells with neuroendocrine differentiation are sparsely scattered in some head and neck squamous cell carcinomas. Their pathophysiological role is elusive. In contrast, somatostatin receptor and particularly somatostatin receptor 5 expression is frequent in head and neck squamous cell carcinoma. Somatostatin receptor expression is not considered to indicate neuroendocrine differentiation in head and neck squamous cell carcinoma. [ABSTRACT FROM PUBLISHER]